DENTSPLY SIRONA (XRAY) 44th Annual J.P. Morgan Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
44th Annual J.P. Morgan Healthcare Conference summary
13 Apr, 2026Executive Leadership and Strategic Vision
New CEO with extensive medtech experience is driving a turnaround focused on sustainable, profitable growth and leveraging best-in-class business models.
Emphasis on brand strength, customer loyalty, and an integrated portfolio to shape the future of connected dentistry via the DS Core platform.
CEO is implementing a return-to-growth plan with measurable actions, aiming for operational urgency and improved execution.
Action plan initiated in November 2025 focuses on customer-centricity, sustainable growth, and performance empowerment.
Market Position and Portfolio
Operates in a $33 billion global dental market with 3%-4% CAGR, serving over 100 countries and training 400,000+ dental professionals annually.
Holds leading positions in chairside, imaging, endodontics, and preventive dental solutions, with over 50 new products launched in four years.
Integrated portfolio spans essential dental, orthodontic, implant, and connected technology solutions.
Connected dentistry strategy leverages technology to streamline workflows and enhance patient-centered care.
Innovation and Digital Transformation
DS Core platform enables connected dentistry, integrating AI-driven diagnostics and streamlined workflows for faster, single-visit treatments.
R&D investment to increase from 4% to 6% of sales over 24 months, focusing on implants, orthodontics, and enhancing DS Core applications.
AI and data analytics are being deployed for operational efficiency and predictive decision-making.
AI-driven workflows and simplified platforms lower barriers to digital adoption and improve efficiency.
DS Core platform enables integration with third-party labs and equipment, supporting comprehensive workflows.
Latest events from DENTSPLY SIRONA
- Virtual meeting to vote on directors, auditors, compensation, and incentive plan amendment.XRAY
Proxy filing23 Apr 2026 - Board recommends FOR all proposals, emphasizing governance, pay-for-performance, and ESG progress.XRAY
Proxy filing23 Apr 2026 - Turnaround strategy centers on execution, innovation, and targeted investments for long-term growth.XRAY
Leerink Global Healthcare Conference 202610 Mar 2026 - Q4 2025 sales rose but FY 2025 declined; restructuring and dividend cut shift focus to growth.XRAY
Q4 202527 Feb 2026 - All proposals, including director elections and incentive plan amendment, were approved by majority vote.XRAY
AGM 20253 Feb 2026 - Transformation and digitalization drive growth, but implants continue to underperform.XRAY
43rd Annual J.P. Morgan Healthcare Conference 20253 Feb 2026 - Q2 sales fell 4.2% to $984M, with a net loss and new cost-saving restructuring underway.XRAY
Q2 20242 Feb 2026 - Transformation and digitalization target $200M+ savings and 500 bps margin growth by 2026.XRAY
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Primescan 2 launch and operational streamlining drive digital growth amid muted dental demand.XRAY
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026